Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Ovarian cancer

  • You have access
    SOX18 Expression Predicts Response to Platinum-based Chemotherapy in Ovarian Cancer
    BARTOSZ PULA, CHRISTOPHER KOBIERZYCKI, DANIEL SOLINSKI, MATUESZ OLBROMSKI, EWA NOWAK-MARKWITZ, MAREK SPACZYNSKI, WITOLD KEDZIA, MACIEJ ZABEL and PIOTR DZIEGIEL
    Anticancer Research August 2014, 34 (8) 4029-4037;
  • You have access
    Mechanisms of Action of 17βH-neriifolin on its Anticancer Effect in SKOV-3 Ovarian Cancer Cell Line
    SITI-SYARIFAH MOHD MUTALIP, NURHANAN MURNI YUNOS, PUTERI SHAFINAZ AKMAR ABDUL-RAHMAN, MUHAMMAD HAFFIZ JAURI, ASIAH OSMAN and MOHD ILHAM ADENAN
    Anticancer Research August 2014, 34 (8) 4141-4151;
  • You have access
    Pre-clinical Study of BK-UM, a Novel Inhibitor of HB-EGF, for Ovarian Cancer Therapy
    SUNG OUK NAM, FUSANORI YOTSUMOTO, KOHEI MIYATA, YUKI SUZAKI, HIROSHI YAGI, TAKASHI ODAWARA, SADAO MANABE, TOYOKAZU ISHIKAWA, MASAHIDE KUROKI, EISUKE MEKADA and SHINGO MIYAMOTO
    Anticancer Research August 2014, 34 (8) 4615-4620;
  • You have access
    Possibilities of Fertility Preservation in Young Patients with Ovarian Cancer
    MELANIE HENES, FELIX NEIS, BERNHARD KRÄMER, CHRISTINA WALTER, SARA BRUCKER, MICHAEL VON WOLFF, RALF ROTHMUND, BARBARA LAWRENZ and KATHARINA RALL
    Anticancer Research July 2014, 34 (7) 3851-3854;
  • You have access
    High Levels of Wilms' Tumor 1 (WT1) Expression Were Associated with Aggressive Clinical Features in Ovarian Cancer
    ZHIYANG LIU, KEIKO YAMANOUCHI, TSUYOSHI OHTAO, SOHEI MATSUMURA, MANABU SEINO, VIJI SHRIDHAR, TOSHIFUMI TAKAHASHI, KAZUHIRO TAKAHASHI and HIROHISA KURACHI
    Anticancer Research May 2014, 34 (5) 2331-2340;
  • You have access
    Pertuzumab: Development Beyond Breast Cancer
    PHILIPPE BARTHÉLÉMY, JULIE LEBLANC, VERONICA GOLDBARG, FRÉDÉRIQUE WENDLING and JEAN-EMMANUEL KURTZ
    Anticancer Research April 2014, 34 (4) 1483-1491;
  • You have access
    Targeted Treatment of Ovarian Cancer - The Multiple - Kinase - Inhibitor Sorafenib as a Potential Option
    ELISABETH SMOLLE, VALENTIN TAUCHER, EDGAR PETRU and JOHANNES HAYBAECK
    Anticancer Research April 2014, 34 (4) 1519-1530;
  • You have access
    Malignant Ascites in Ovarian Cancer and the Role of Targeted Therapeutics
    ELISABETH SMOLLE, VALENTIN TAUCHER and JOHANNES HAYBAECK
    Anticancer Research April 2014, 34 (4) 1553-1561;
  • You have access
    Synthesis and Antitumour Activity of a New Trinuclear Platinum Compound [{cis-PtCl(NH3)2μ {trans-Pt(3-hydroxypyridine)2H2N(CH2)5NH2)2}] Cl4 in Human Ovarian Cancer Cells
    SHAHNAZ A. HAMAD, PHILIP BEALE, JUN QING YU and FAZLUL HUQ
    Anticancer Research April 2014, 34 (4) 1923-1929;
  • You have access
    Biomarkers for Predicting Complete Debulking in Ovarian Cancer: Lessons to Be Learned
    CARSTEN LINDBERG FAGÖ-OLSEN, BENT OTTESEN, IB JARLE CHRISTENSEN, ESTRID HØGDALL, LENE LUNDVALL, LOTTE NEDERGAARD, SVEND-AAGE ENGELHOLM, SOFIE LEISBY ANTONSEN, MAGNUS LYDOLPH and CLAUS HØGDALL
    Anticancer Research February 2014, 34 (2) 679-682;

Pages

  • Previous
  • Next
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire